04-Oct-2006 - Indian biopharmaceutical company Wockhardt has signed a deal with Maharashtra Industrial Development Corporation (MIDC) to establish a special economic zone (SEZ) in Aurangabad, India, in order to expand its manufacturing capabilities.
04-Oct-2006 - Following numerous manufacturing failures, Discovery Laboratories believes it has resolved the stability issues that have plagued Surfaxin, its experimental respiratory treatment for infants, and is now seeking a meeting with the US Food and Drug Administration (FDA) to address its concerns.
02-Oct-2006 - Drug developing services provider Aptuit has acquired the pharmaceutical services division of technology firm EaglePicher, enriching its active pharmaceutical ingredient (API) and drug substance manufacturing offerings.
26-Sep-2006 - Ferro Pfanstiehl Laboratories has commissioned a new validated current good manufacturing practice (cGMP) supercritical fluid-based particle engineering pilot facility, offering sizing, purification and formulation services to its pharmaceutical customers.
25-Sep-2006 - Patheon's move to Puerto Rico is shaping up to be the worst decision the contract manufacturer has ever made, resulting in massive losses in the third quarter of 2006 and leading management to entertain the possibility of a sell-out.
22-Sep-2006 - Bentley Pharmaceuticals has announced it will use the North Carolina facilities of US-based services provider Cardinal Health for the scale-up and manufacture of the clinical supplies of its new intranasal insulin product.
19-Sep-2006 - Cardinal Health has been given the green light from the US Food and Drug Administration (FDA) to start manufacturing the first commercial drug at its new sterile facility in North Carolina.
18-Sep-2006 - Kemwell has sealed the deal on the purchase of Pfizer's Swedish manufacturing plant and at the same time secured a long-term contract manufacturing agreement with the drug giant.
14-Sep-2006 - Successful technology transfer and effective management can help avoid disappointment with contract manufacturing arrangements, which often fail to live up to pharmaceutical company expectations.
14-Sep-2006 - Wyeth has entered into a global agreement that allows it to use Intracell's synthetic adjuvant IC31 in the formulation of five of its investigational vaccines, aiming to simply mix it with antigens without the need for conjugation.
13-Sep-2006 - A good selection process, with a realistic set of selection criteria is essential when looking for the right contract manufacturing partner, according to a new Datamonitor report.
12-Sep-2006 - Offshoring contract manufacturing is not the only option for large pharma firms looking to drive productivity and efficiency gains in drug manufacturing, warns a new report from independent market analyst Datamonitor.
05-Sep-2006 - After selling a manufacturing plant in Texas to Cardinal Health two years ago, Adams Respiratory Therapeutics has reacquired the facility in order to produce its expectorant Mucinex (guaifenesin extended-release), responding to a 15-fold growth in sales in the last couple of years.
29-Aug-2006 - Canadian contract manufacturer Patheon has teamed up with specialty pharmaceutical firm Depomed to offer its clients a controlled release formulation which can grant their drugs increased bioavailability and less frequent dosing.
23-Aug-2006 - Despite its consolidation, the competitive consumable sector still offers potential for rapid growth and better profits in the biopharmaceutical industry, while contract bioprocessing services will be increasingly in demand, according to a new market report by D&MD Publications titled "The Bioprocessing Industry - Increasing Capacity, Production, and Efficiency."
23-Aug-2006 - For the first time Merck has opened the doors of its under-construction manufacturing plant in North Carolina to public officials, boasting it will eventually contribute about two-thirds of its annual live-virus vaccine production.
17-Aug-2006 - Newly-approved pearlescent pigments that can produce sparkly metallic, satiny and shimmery finishes on drug coatings could be used as one additional step in the fight against counterfeiting, say its developers, EMD Chemicals - part of part of German drug giant Merck.
15-Aug-2006 - India's potential to further boost its already dominant role in global generics production, as well as an offshore location of choice for contract manufacturing, presents an opportunity worth an estimated $48bn (€38bn) in 2007, though regulatory reforms and improved intellectual property rights are needed if its domestic market is to be tapped, a new report from KPMG suggests.
15-Aug-2006 - More problems at Patheon's Puerto Rican production facilities in the third quarter of 2006 are expected to reduce the contract manufacturer's earnings before interest, tax, depreciation and amortisation (EBITDA) by more than $9m (€7m) compared to last year, forcing it to negotiate its credit agreement with its lenders.
08-Aug-2006 - West Pharmaceutical Services has reported a huge surge in both sales and profits for its second quarter, spurred on by the increasing demand for injectable drugs as well as the lucrative Exubera manufacturing contract, which helped double sales for the segment, although failed to stop a fall in profit margin.
08-Aug-2006 - Pharmaceutical excipients can have a profound impact on the release profile of drugs, driving fine chemical companies to raise their game since they realise their clients see excipients as more than inactive ingredients.
03-Aug-2006 - More and more drugmakers are turning to health care companies not just for their drug delivery technologies but also for their regulatory and manufacturing expertise, asking them to take their product from early stages all the way to post-approval.
20-Jul-2006 - The Japanese pharmaceutical industry is eyeing India as a new hub to conduct its contract manufacturing and clinical trials - India is thirsty for new Japanese investment.
29-Jun-2006 - After launching its flagship oral insulin spray in Ecuador last December, Generex is finally gearing up to take on big pharma in the global non-injectable insulin arena and has picked Cardinal Health to help meet manufacturing demands.
18-May-2006 - Cardinal Health has taken the contract manufacturing crown after being honoured with a prestigious award from Frost & Sullivan in recognition of its ability to provide biopharma firms with a high quality service, while still remaining extremely competitively priced.